Hellström, William
Hortensius, Lisa M.
Löfqvist, Chatarina
Hellgren, Gunnel
Tataranno, Maria Luisa
Ley, David
Benders, Manon J.N.L.
Hellström, Ann
Björkman–Burtscher, Isabella M.
Heckemann, Rolf A.
Sävman, Karin
Article History
Received: 20 January 2022
Revised: 17 May 2022
Accepted: 23 May 2022
First Online: 9 June 2022
Competing interests
: A.H. and C.L. hold stock/stock options in Premalux AB. In addition, A.H. and D.L. have received consulting fees from Shire, a Takeda company. The rest of the authors declare no competing interests.
: Written informed parental consent was required prior to the study enrollment of the infant.